Dimitra Argyro V.
- Country
- Greece
- Department
- Department of Endocrinology and Metabolism, Diabetes Centre
Research Overview
- Phase 3 Randomized Double‑Masked Placebo‑Controlled Study of Subcutaneous Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
- A 40-Week Randomized Study Evaluating the Efficacy and Safety of Weekly Insulin Icodec/Semaglutide Versus Daily Insulin Glargine in Type 2 Diabetes Patients
- Evaluation of Crinecerfont (NBI-74788) Efficacy and Safety in Adults with Classic Congenital Adrenal Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 20 of 123 partner sites.
Specializations
Endocrine Disorders
Specializes in the treatment of complex endocrine conditions, with particular emphasis on acromegaly management and innovative therapeutic approaches. The investigator evaluates novel oral treatments for patients with this rare endocrine disorder.
- Growth hormone regulation
- IGF-1 level management
- Long-term disease control
Contributes to advancing treatment options for patients requiring sustained hormonal regulation.
Metabolic Diseases
Focuses on innovative treatments for Type 2 diabetes, particularly investigating combination therapies involving next-generation insulin formulations and glucagon-like peptide-1 receptor agonists.
- Glycemic control optimization
- Weekly insulin administration
- Combination therapy approaches
Explores advanced treatment strategies for improving diabetes management and patient outcomes.
Genetic Endocrine Conditions
Investigates therapeutic solutions for Classic Congenital Adrenal Hyperplasia, focusing on novel treatments to improve hormone regulation and reduce dependence on traditional glucocorticoid therapy.
- Adrenal steroid management
- Glucocorticoid optimization
- Hormone level control
Develops targeted approaches for managing rare genetic endocrine disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.